Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Inflammatory eye disorders
•
Ophthalmology
What is your treatment approach for bilateral peripheral ulcerative keratitis that has been resistant to topical treatment in a patient with negative infectious and autoimmune workup?
Related Questions
In a patient with isolated HLA B27+ anterior uveitis, how long would you continue immunosuppressive therapy?
How would you approach the management of dry corneal melt in a patient requiring high dose systemic steroids and no apparent underlying systemic autoimmune disease?
How do you optimize retinopathy screening schedules for patients on hydroxychloroquine while also prioritizing cost-effectiveness?
How do you treat idiopathic acute anterior uveitis that recurs immediately after a course of topical corticosteroids?
How do you approach the management of recurrent episcleritis in a patient with RA that is otherwise well-controlled?
Is it safe to continue azathioprine in a patient with severe bilateral panuveitis (thought to be related to sarcoidosis) and benign ethnic neutropenia, given worsening neutropenia since starting the medication, or should an alternative immunosuppressive agent be considered?
How would you approach management of nodular scleritis in the setting of suspected GCA?
What is your recommended rheumatic disease evaluation for a pediatric patient presenting with interstitial keratitis and a negative infectious disease workup (e.g., HSV, syphilis, Lyme)?
Would you consider using a JAK inhibitor for a patient with RA associated scleritis?
What is your approach to the diagnosis and management of optic chiasmitis in systemic lupus erythematosus?
